S4 Ep38: Accelerating MedTech Innovation and First-in-Human Success with Julio Martinez-Clark, Co-Founder & CEO of bioaccess
This week on Tech Can't Save Us, host Paul David is joined by Julio Martinez-Clark, co-founder and CEO of BioAccess, the world's first contract research organization (CRO) purpose-built specifically for first-in-human (FIH) clinical trials. They discuss the "valley of death" that claims roughly 90% of healthcare startups, which frequently fail not because their technology is flawed, but because they run out of capital before securing vital clinical data.
Julio explains how BioAccess helps medtech, biopharma, and radiopharma startups bypass these bottlenecks by compressing clinical timelines…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.